Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The pathogenic bacteria cell wall and membrane integrity refer collectively to the structural features that maintain bacterial shape and protect against environmental stresses. The main component is peptidoglycan in most bacteria—a mesh-like polymer that provides rigidity—while gram-negative species also possess an additional outer lipopolysaccharide-containing membrane. These structures are essential targets for many antibiotics because their disruption leads directly to bacterial death via osmotic lysis or loss of essential barrier functions. Drugs targeting these structures include β-lactams (penicillins), glycopeptides (vancomycin), bacitracin, polymyxins (colistin/polymyxin B/E), and lipopeptides like daptomycin. Bacteria can adapt by modifying their cell walls or switching between different forms with reduced dependence on these structures as part of resistance mechanisms.
Inhibition of peptidoglycan synthesis leading to weakened cell walls and osmotic lysis; Disruption of outer or cytoplasmic membranes causing loss of structural integrity; Insertion into membranes leading to leakage of cellular contents. Specifically: β-lactams inhibit transpeptidase enzymes involved in peptidoglycan cross-linking; Glycopeptides bind directly to peptidoglycan precursors; Bacitracin blocks lipid carrier recycling needed for peptidoglycan synthesis; Polymyxins interact with lipopolysaccharide in gram-negative bacteria’s outer membrane; Lipopeptides insert into cytoplasmic membranes of gram-positive bacteria.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pathogenic bacteria cell wall and membrane integrity.